The Best Stocks for the Rest of Trump’s Term: Stryker Corporation (SYK)
It has become a forgotten detail of Obamacare’s advent, but to help fund some pieces of the healthcare system’s overhaul, the new rules imposed a 2.3% excise tax on the medical equipment manufacturers. The exact adverse impact on these companies has been difficult to measure, though nobody would argue it hasn’t created some sort of headwind.
If President Trump gets his way — and looks like he will sooner or later — that excise tax is going away, and that bodes well for medical equipment makers.
There are plenty to choose from, but Stryker Corporation (NYSE:SYK) has earned a spot on the list of stocks to buy on expectations that the restrictive cost of doing business will be lifted.
Despite the imposition of the added cost, the company just topped its Q1 earnings and revenue estimates. It could do even more without the financial sandbag it’s forced to drag along.